Literature DB >> 25010442

Genetics of juvenile idiopathic arthritis: new tools bring new approaches.

Halima Moncrieffe1, Sampath Prahalad, Susan D Thompson.   

Abstract

PURPOSE OF REVIEW: In juvenile idiopathic arthritis (JIA), there are now more than 25 regions represented by single nucleotide polymorphisms that show strong genetic associations. The causal variants and corresponding functions have not yet been defined for the majority of these regions. Here, we review current JIA association findings and the recent progress in the annotation of noncoding portion of the human genome as well as the new technologies necessary to apply this knowledge to JIA association findings. RECENT
FINDINGS: An international collaboration was able to amass sufficient numbers of JIA and control samples to identify significantly robust genetic associations for JIA. The Encyclopedia of DNA Elements project and the National Institutes of Health (NIH) Roadmap Epigenetics Program have now annotated more than 80% of the noncoding genome, important in understanding the impact of risk loci, the majority of which fall outside of protein coding regions. Recent technological advances in high throughput sequencing, chromatin structure determination, transcription factor and enhancer binding site mapping and genome editing will likely provide a basis for understanding JIA genetic risk.
SUMMARY: Understanding the role of genetic variation in the cause of JIA will provide insight for disease mechanism and may explain disease heterogeneity between JIA subtypes and between autoimmune diseases in general.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25010442      PMCID: PMC4445412          DOI: 10.1097/BOR.0000000000000094

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  58 in total

1.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.

Authors:  Xuebing Wu; David A Scott; Andrea J Kriz; Anthony C Chiu; Patrick D Hsu; Daniel B Dadon; Albert W Cheng; Alexandro E Trevino; Silvana Konermann; Sidi Chen; Rudolf Jaenisch; Feng Zhang; Phillip A Sharp
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

2.  Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.

Authors:  Seung Woo Cho; Sojung Kim; Jong Min Kim; Jin-Soo Kim
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

3.  Targeted genome editing across species using ZFNs and TALENs.

Authors:  Andrew J Wood; Te-Wen Lo; Bryan Zeitler; Catherine S Pickle; Edward J Ralston; Andrew H Lee; Rainier Amora; Jeffrey C Miller; Elo Leung; Xiangdong Meng; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Barbara J Meyer
Journal:  Science       Date:  2011-06-23       Impact factor: 47.728

4.  High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells.

Authors:  Yuexin Zhou; Shiyou Zhu; Changzu Cai; Pengfei Yuan; Chunmei Li; Yanyi Huang; Wensheng Wei
Journal:  Nature       Date:  2014-04-09       Impact factor: 49.962

5.  IL-32 promotes angiogenesis.

Authors:  Claudia A Nold-Petry; Ina Rudloff; Yvonne Baumer; Menotti Ruvo; Daniela Marasco; Paolo Botti; Laszlo Farkas; Steven X Cho; Jarod A Zepp; Tania Azam; Hannah Dinkel; Brent E Palmer; William A Boisvert; Carlyne D Cool; Laima Taraseviciene-Stewart; Bas Heinhuis; Leo A B Joosten; Charles A Dinarello; Norbert F Voelkel; Marcel F Nold
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

6.  Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects.

Authors:  Jill A Hollenbach; Susan D Thompson; Teodorica L Bugawan; Mary Ryan; Marc Sudman; Miranda Marion; Carl D Langefeld; Glenys Thomson; Henry A Erlich; David N Glass
Journal:  Arthritis Rheum       Date:  2010-06

7.  Evaluation of methods for modeling transcription factor sequence specificity.

Authors:  Matthew T Weirauch; Atina Cote; Raquel Norel; Matti Annala; Yue Zhao; Todd R Riley; Julio Saez-Rodriguez; Thomas Cokelaer; Anastasia Vedenko; Shaheynoor Talukder; Harmen J Bussemaker; Quaid D Morris; Martha L Bulyk; Gustavo Stolovitzky; Timothy R Hughes
Journal:  Nat Biotechnol       Date:  2013-01-27       Impact factor: 54.908

8.  High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.

Authors:  Steve Eyre; John Bowes; Dorothée Diogo; Annette Lee; Anne Barton; Paul Martin; Alexandra Zhernakova; Eli Stahl; Sebastien Viatte; Kate McAllister; Christopher I Amos; Leonid Padyukov; Rene E M Toes; Tom W J Huizinga; Cisca Wijmenga; Gosia Trynka; Lude Franke; Harm-Jan Westra; Lars Alfredsson; Xinli Hu; Cynthia Sandor; Paul I W de Bakker; Sonia Davila; Chiea Chuen Khor; Khai Koon Heng; Robert Andrews; Sarah Edkins; Sarah E Hunt; Cordelia Langford; Deborah Symmons; Pat Concannon; Suna Onengut-Gumuscu; Stephen S Rich; Panos Deloukas; Miguel A Gonzalez-Gay; Luis Rodriguez-Rodriguez; Lisbeth Ärlsetig; Javier Martin; Solbritt Rantapää-Dahlqvist; Robert M Plenge; Soumya Raychaudhuri; Lars Klareskog; Peter K Gregersen; Jane Worthington
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

9.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

Review 10.  Next-generation sequencing and epigenomics research: a hammer in search of nails.

Authors:  Shrutii Sarda; Sridhar Hannenhalli
Journal:  Genomics Inform       Date:  2014-03-31
View more
  6 in total

1.  HLA Associations in a Cohort of Children With Juvenile Idiopathic Arthritis With and Without Uveitis.

Authors:  Sheila T Angeles-Han; Courtney McCracken; Steven Yeh; Se Ryeong Jang; Kirsten Jenkins; Spencer Cope; John Bohnsack; Aimee Hersh; Susan D Thompson; Sampath Prahalad
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

2.  Tumor necrosis factor-α -308 A/G gene polymorphism in children with juvenile idiopathic arthritis: relation to disease activity, damage, and functional status.

Authors:  Iman I El Gazzar; Hanan M Fathy; Tamer A Gheita; Abeer M Nour El-Din; Enas Abdel Rasheed; Rasha H Bassyouni; Sanaa A Kenawy
Journal:  Clin Rheumatol       Date:  2017-06-07       Impact factor: 2.980

3.  Genetic insights into juvenile idiopathic arthritis derived from deep whole genome sequencing.

Authors:  Laiping Wong; Kaiyu Jiang; Yanmin Chen; James N Jarvis
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

Review 4.  Review of environmental factors and juvenile idiopathic arthritis.

Authors:  Daniel B Horton; Susan Shenoi
Journal:  Open Access Rheumatol       Date:  2019-11-06

Review 5.  The Multi-Omics Architecture of Juvenile Idiopathic Arthritis.

Authors:  Xiaoyuan Hou; Huiqi Qu; Sipeng Zhang; Xiaohui Qi; Hakon Hakonarson; Qianghua Xia; Jin Li
Journal:  Cells       Date:  2020-10-15       Impact factor: 6.600

6.  New or vanishing frontiers: LACC1-associated juvenile arthritis.

Authors:  Sulaiman M Al-Mayouf; Mada Yateem; Haya Al-Dusery; Dorota Monies; Salma Wakil; Manal AlShiakh; Abdullatif AlEnazi; Boshra Aladaileh; Raed Alzyoud; Brian Meyer
Journal:  Int J Pediatr Adolesc Med       Date:  2020-11-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.